Opiant Pharmaceuticals Inc (OPNT) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Opiant Pharmaceuticals Inc   (NASDAQ: OPNT)


Opiant Pharmaceuticals Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Opiant Pharmaceuticals Inc 's ROA in the third quarter of 2022?
Opiant Pharmaceuticals Inc recorded a cumulative net loss of $-33 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -60.36%.

However, within the Healthcare sector 840 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2022 from 4678 to 4999.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Total Assets Change -41.2 % -19.48 % 2.53 % 16.53 % 60.93 %
Y / Y Net Income Change - - - - 371.34 %
Net Income (TTM) in million -33 -20 -6 3 2
Return On Assets (TTM) -60.36 % -31.95 % -9.78 % 4.67 % 2.54 %
OPNT's Total Ranking # 4999 # 4678 # 3998 # 1792 # 1968
Total Assets (TTM) in million 40 49 60 70 68
Seq. Total Assets Change -18.12 % -18.95 % -14.24 % 3.33 % 12.11 %
Seq. Net Income Change - - - -77.98 % 102.96 %

OPNT's 5 Years Annual ROA >> Back to OPNT Management Effectiveness >> Compare OPNT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 392
Sector # 841
Overall # 4894

Return On Assets Statistics
High Average Low
194.09 %
-878.41 %
-18084.4 %
(Jan 31 2017)   (Jan 31 2013)





Financial Statements
Opiant Pharmaceuticals Inc 's Assets $ 40 million OPNT's Balance sheet
Opiant Pharmaceuticals Inc 's Income $ -10 million Quarterly OPNT's Income Statement
OPNT's Income by Division See OPNT's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change 16.53 % 49.66 % 37.07 % 41.46 % 1003.86 %
Total Assets in million 70 60 40 29 21
Y / Y Net Income Change - - - - -
Net Income in million 3 -2 12 -21 7
Annual Return On Assets 4.28 % -3.09 % 28.78 % -72.13 % 31.68 %

OPNT's 5 Years Annual ROA >> Back to OPNT Management Effectiveness >> Compare OPNT ROA to its Competitors



Comment on OPNT's ROA in the fiscal year ending 2021
In the fiscal year 2021 ROA improved to 4.28 % compared to prior year, due to annual net income growth of % to $3.01 million, while value of Opiant Pharmaceuticals Inc 's overall assets grew just by 16.53 % to $70.25 million, compared to $70.25 a year before.


More Return On Assets Ratios
OPNT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OPNT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OPNT's Competitors
Subscribers only: Roa for Opiant Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for OPNT's Customers

You may also want to know
OPNT's Roi OPNT's Inventory Turnover Ratio OPNT's Growth Rates OPNT's Dividend Comparisons
OPNT's Profitability Ratios OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Roe OPNT's Valuation Ratios OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.